Articles citing this paper
55. HIGH EFFICACY OF A HPV-16/18 L1 VIRUS-LIKE PARTICLE (VLP) VACCINE ADJUVANTED WITH AS04 AGAINST CIN2+ CAUSED BY HPV-16/18 INFECTION IN A BROAD POPULATION OF YOUNG WOMEN
S. R. Skinner, S. M. Garland, I. Denham, M. O'Sullivan, R. Waddell, A. Mindel and on behalf of the HPV PATRICIA study group
4(4) pp.305 - 306
2 articles found in Crossref database.
AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
Schwarz Tino F
Expert Review of Vaccines. 2008 7(10). p.1465
Place de la vaccination antipapillomavirus après 25 ans
Simon P., Poppe W.
Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 2008 37(8). p.748
